Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Investors Breathe Easy On ResMed Inc (ASX:RMD) First Quarter Result

ResMed Inc (ASX:RMD) has reported its result for the first quarter of the 2019 financial year.

ResMed Inc (ASX: RMD) has reported its result for the first quarter of the 2019 financial year.

ResMed is a healthcare business that uses devices to help treat and manage sleep apnea, chronic obstructive pulmonary diseases and other respiratory conditions.

First quarter result:

ResMed reported that revenue grew by 12% to US$588.3 million, and it grew by 13% in constant currency terms.

Net income grew by 23% to US$105.7 million year-on-year, and earnings per share (EPS) increased by 22% to 73 cents per share.

ResMed CEO Mick Farrell commented on some of the company’s recent activities:

During the quarter we expanded our product portfolio with new masks and made ongoing upgrades to our digital health solutions, separating ResMed from the competition.”

Some of those upgrades were to the Astral life support ventilator. It also introduced the AirFit F30, which is the company’s first minimal-contact full face CPAP mask.

The company said it completed the acquisition of HEALTHCAREfirst, a provider of software solutions and services for home health and hospice agencies for US$126.3 million.

ResMed also announced a joint venture with Verily, owned by Alphabet Inc (NASDAQ: GOOGL), which aims to combine ResMed’s expertise in sleep apnea and Verily’s health data analytics, to study the health and financial impacts of undiagnosed sleep apnea and how to effectively treat it.

The ResMed share price was up 6% in early trade on Friday, according to CommSec. ResMed recently reported a fall of profit in its FY18 result.

Free Investing Report: 3 Proven ASX Shares

The Rask Group Pty Ltd has just issued a brand-new investing research report on 3 proven ASX dividend + growth sharesClick here to access the free report. No credit card or payment required. (sponsored)

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content